QGEN vs WST
Qiagen N.V. vs West Pharmaceutical Services — AI-powered side-by-side comparison
VS
WST
West Pharmaceutical Services
74
Buy
| Metric | QGEN | WST |
|---|
| AI Score |
64
|
74
|
| Price |
$42.66
|
$351.74
|
| P/E Ratio |
21.87×
|
44.65×
|
| ROE |
11.2%
|
15.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
61.7%
|
36.8%
|
| Debt / Equity |
0.49×
|
0.10×
|
| Dividend Yield |
6.2%
|
0.3%
|
| RSI (14) |
57.5
|
58.0
|
| Beta |
0.62
|
1.138
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for QGEN versus WST.
WST leads by 10 points.
WST scores 74/100 (Buy) versus QGEN at 64/100 (Buy).
QGEN Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- EPS growing 341.4% YoY — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
WST Committee View
100% agreement
5 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical